ARTICLE | Clinical News

Texas Biotech regulatory update

July 25, 1994 7:00 AM UTC

The Houston company said Immuno-Pharmaceutics Inc. has received U.S. patent No. 5,331,573, covering a supercomputer-based rational drug design technology. TXB is in the process of finalizing a letter of intent to acquire the San Diego company. ...